Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP365451.RAalP6C4NlFagw457lyB4bNrwrhSNi4OBttzV9oaJe62E130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365451.RAalP6C4NlFagw457lyB4bNrwrhSNi4OBttzV9oaJe62E130_provenance.
• assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP729118.RAfdpI2YI2vIfKnCwOEBgpYvNsmYj6l_QzzlY69JGMITw130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP729118.RAfdpI2YI2vIfKnCwOEBgpYvNsmYj6l_QzzlY69JGMITw130_provenance.
• NP304493.RAymzsKrvs4O05kEXQgpgOuS1PKQhb4QQuGeMZrHxy4xY130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304493.RAymzsKrvs4O05kEXQgpgOuS1PKQhb4QQuGeMZrHxy4xY130_provenance.
• NP256858.RA5L7Ngb2Qefs3_Hxs3xhbQbU639L5cU1KJNBbyTdpupI130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256858.RA5L7Ngb2Qefs3_Hxs3xhbQbU639L5cU1KJNBbyTdpupI130_provenance.
• NP612769.RA904tmkYoTWV5Uq7hXZIT9xODCG8LCjCJ3RLZ12IEGHI130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612769.RA904tmkYoTWV5Uq7hXZIT9xODCG8LCjCJ3RLZ12IEGHI130_provenance.
• NP711276.RAeV_Ikd4k96IT1SES0HGK0Yfx-rxzgszFnlLz_zRbf_s130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711276.RAeV_Ikd4k96IT1SES0HGK0Yfx-rxzgszFnlLz_zRbf_s130_provenance.
• assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP747547.RAa_dtdF5FUausXl5A3HUskOMlWqSPN46M0zNS9kUDoyE130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747547.RAa_dtdF5FUausXl5A3HUskOMlWqSPN46M0zNS9kUDoyE130_provenance.
• NP747548.RAfGFd5ackhPdjjkzQdM2jFqdFJayL1iZzb9VHsuSorAA130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747548.RAfGFd5ackhPdjjkzQdM2jFqdFJayL1iZzb9VHsuSorAA130_provenance.
• NP427961.RA_o-Xjf06pMPbyMAm5ipH-XFw7PD2AndsgjiltCCfUEc130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427961.RA_o-Xjf06pMPbyMAm5ipH-XFw7PD2AndsgjiltCCfUEc130_provenance.
• NP428059.RA_mJ016XiMH73joflhVAuENvV3a_WA2J0L8LvQIDGhvk130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428059.RA_mJ016XiMH73joflhVAuENvV3a_WA2J0L8LvQIDGhvk130_provenance.
• NP711050.RAOZUyT8Dpo1dwVeeAE75KPNpmJB0IGj-WuRjnc0nCL-w130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711050.RAOZUyT8Dpo1dwVeeAE75KPNpmJB0IGj-WuRjnc0nCL-w130_provenance.
• NP747546.RA8epnDHmPeQSRzflC3Ed573m-LXJqMMwJ79LSsSwoNlc130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747546.RA8epnDHmPeQSRzflC3Ed573m-LXJqMMwJ79LSsSwoNlc130_provenance.
• NP747549.RA3FSlNKGflT270WMKsxX9XhmoVSLCJF6meYgmkvdhEbE130_assertion description "[In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747549.RA3FSlNKGflT270WMKsxX9XhmoVSLCJF6meYgmkvdhEbE130_provenance.